ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
200961-1G |
|
4984-22-9 |
(2R)-1-Methoxy-2-propanol ≥98%,99%e.e. |
1G | C4H10O2 | |
200955-100MG |
|
NA |
(5aS,?10bR)?-?5a,?10b-?Dihydro-?5-(9-anthracene)-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate ≥98%,99%e.e. |
100MG | C32H21Br3N3O·BF4 | |
200954-100MG |
|
NA |
(5aR,?10bS)?-?5a,?10b-?Dihydro-?5-(9-anthracene)-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate ≥98%,99%e.e. |
100MG | C32H21Br3N3O·BF4 | |
200953-100MG |
|
NA |
(5aS?,?10bR)?-?5a,?10b-?Dihydro-5-?(9-phenanthrene)-2-(?(2,?6-?dibromo-4-trifluoromethyl)phenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate ≥98%,99%e.e. |
100MG | C33H21F3Br2N3O·BF4 | |
200952-100MG |
|
NA |
(5aR,?10bS)?-?5a,?10b-?Dihydro-?5-(9-phenanthrene)-2-(?(2,?6-?dibromo-4-trifluoromethyl)phenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate ≥98%,99%e.e. |
100MG | C33H21F3Br2N3O·BF4 | |
200937-100MG |
|
NA |
(5aS,?10bR)?-?5a,?10b-?Dihydro-?5-(1-naphthalene)-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate ≥98%,99%e.e. |
100MG | C28H19Br3N3O·BF4 | |
200951-100MG |
|
NA |
(5aR,?10bS)?-?5a,?10b-?Dihydro-?5-(1-naphthalenyl)-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate ≥98%,99%e.e. |
100MG | C28H19Br3N3O·BF4 | |
200936-100MG |
|
NA |
(5aS,?10bR)?-?5a,?10b-?Dihydro-?5-phenyl-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate ≥98%,99%e.e. |
100MG | C24H17Br3N3O·BF4 | |
200950-100MG |
|
NA |
(5aR,?10bS)?-?5a,?10b-?Dihydro-?5-phenyl-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate ≥98%,99%e.e. |
100MG | C24H17Br3N3O·BF4 | |
200935-100MG |
|
NA |
(5aS?,?10bR)?-?5a,?10b-?Dihydro-?2-(?(2,?6-?dibromo-4-trifluoromethyl)phenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate ≥98%,99%e.e. |
100MG | C19H13F3Br2N3O·BF4 | |
200949-100MG |
|
NA |
(5aR,?10bS)?-?5a,?10b-?Dihydro-?2-(?(2,?6-?dibromo-4-trifluoromethyl)phenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate ≥98%,99%e.e. |
100MG | C19H13F3Br2N3O·BF4 | |
200929-25G |
|
133170-58-8 |
D-Valinamide Hydrochloride ≥98%,99%e.e. |
25G | C5H12N2O?HCl | |
200929-5G |
|
133170-58-8 |
D-Valinamide Hydrochloride ≥98%,99%e.e. |
5G | C5H12N2O?HCl | |
200929-1G |
|
133170-58-8 |
D-Valinamide Hydrochloride ≥98%,99%e.e. |
1G | C5H12N2O?HCl | |
200927-1G |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥95%,99%e.e. |
1G | C45H55O4P | |
200927-100MG |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥95%,99%e.e. |
100MG | C45H55O4P | |
200927-25MG |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
25MG | C45H55O4P | |
200926-1G |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥95%,99%e.e. |
1G | C45H55O4P | |
200926-100MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥95%,99%e.e. |
100MG | C45H55O4P | |
200926-25MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
25MG | C45H55O4P | |